| Trichomonas vaginalis (TV) genetic diversity and the influence of Trichomonas vaginalis viruses (TVVs) in determining the severity of clinical manifestations of the lower female reproductive tract (FRT) | Life Sciences & Biotechnology, Medical Sciences | 2017 | 2020 |
| Understanding role of DNA polymerase eta dependent trans-lesion DNA synthesis in pathogenicity of Candida albicans | Life Sciences & Biotechnology, Medical Sciences | 2016 | 2019 |
| Understanding the assembly of nuclear export complex on HBV RNAs | Life Sciences & Biotechnology, Medical Sciences | 2018 | 2021 |
| Understanding the machinery involved in positioning a unique motif of Helicobacter pylori arginase and its implication to design a novel class of inhibitors | Life Sciences & Biotechnology, Medical Sciences | 2017 | 2020 |
| Understanding the role of RevStaufen interactions in regulating HIV-1 propagation by altering cytoplasmic mRNA silencing foci and nuclear membrane architecture | Life Sciences & Biotechnology, Medical Sciences | 2016 | 2019 |
| Understanding the role of Rv1955-Rv1956 Toxin-antitoxin (TA) locus of Mycobacterium tuberculosis in pathogen biology | Life Sciences & Biotechnology, Medical Sciences | 2016 | 2019 |
| Understanding the roles of ClpX and ClpC1 components of Clp proteolytic machinery in Mycobacterium tuberculosis | Life Sciences & Biotechnology, Medical Sciences | 2018 | 2021 |
| Vaccination and protection studies for a targeted nanoparticulate oral vaccine against shigellosis | Life Sciences & Biotechnology, Medical Sciences, Pharmaceutical Sciences | 2018 | 2020 |
| Validation of novel bio-signature for diagnosis of active pulmonary tuberculosis in children | Life Sciences & Biotechnology, Medical Sciences | 2018 | 2019 |
| Virtual centre of excellence on multidisciplinary approaches aimed at interventions against Mycobacterium tuberculosis (Phase II) | Life Sciences & Biotechnology, Medical Sciences, Pharmaceutical Sciences | 2015 | 2020 |